KRT17 and cancer: Therefore, we used databases or webservers such as TCGA, Tumor Immune Estimation Resource 2.0 (TIMER2.0), GEO, and Gene Expression Profiling Interactive Analysis 2 (GEPIA2) to conduct pan-cancer analysis of KRT17 and explore the potential molecular mechanisms by which it relates to the occurrence, development, and clinical prognosis of different cancer types.